FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for…
A structured and well-documented Gap Analysis is essential for identifying deficiencies, strengthening compliance, and ensuring…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CDSCO
AstraZeneca gains CDSCO approval to import SZC for treating Hyperkalaemia in adult patients
This treatment can enhance hyperkalaemia management in adults, a condition characterised by elevated potassium levels that often…
CDSCO launches online registration process for CROs
As per the Health Ministry, registration of CROs will become mandatory with effect from April 1, 2025
Biovet receives CDSCO licence DIVA marker vaccine for lumpy skin disease
BIOLUMPIVAXIN, developed with ICAR, is reportedly India’s first LSD vaccine
Understanding opportunities and challenges for SMEs after breather on Schedule M deadline
Akshansh Chaudhary, Executive Director & Chief Technical Officer, Venus Remedies highlights the challenges SMEs face and how…
India’s biopharma industry needs to become a little bit more ambitious
In a free wheeling conversation with Viveka Roychowdhury, Dr Dhananjay Patankar, biopharma consultant, explains why Indian…
Revised Schedule M implementation for MSMEs extended, industry welcomes move
The timeline of implementation is extended till December 31, 2025 but pharma MSMEs must file an application with the Central…
Spurious drugs worth Rs. 6.60 cr seized in Kolkata
The drugs, labelled as being manufactured in various countries including Ireland, Turkey, the USA, and Bangladesh, were found…
CDSCO flags two drugs as spurious, another 111 listed as NSQ
Select batches of Pan-40 and Augmentin 625 Duo flagged as spurious
AIPAC launches first training programme for Pharma MSMEs in Indore
The collaborative programme seeks to bridge the knowledge gap for MSMEs in the pharmaceutical industry